Imatinib Mesylate Effectiveness in Chronic Myeloid Leukemia with Additional Cytogenetic Abnormalities at Diagnosis among Black Africans

Table 2

List of additional cytogenetic anomalies at diagnosis of the 27 patients in the study.

No patient	Cytogenetic abnormalities
1	47,XX, +8, t (9;22) (q34;11) [100]
2	47,XY, +8, t (9;22) (q34;11) [1]
3	47,XX, +8, t (9;22) (q34;11) [1]
4	47,XX, +8, t (9;22) (q34;11) [1]
5	46,XY, t (9;22) (q34;q11), add (1) (p36.3) [12]
6	46,XY, t (9;22) (q34;q11), add (2) (p25) [6]
7	46,XX, del (7) (q22;q31), t (9;22) (q34;q11) [100]
8	46,XY, del (7) (q31), t (9;22) (q34;q11) [2]
9	46,XY, del (12) (p12), t (9;22) (q34;q11) [12]
10	46,XY, del (3) (p12p14), t (9;22) (q34;q11) [5]
11	46,XX, del (1) (q12) add (1) (q44), t (9;22) (q34;11) [3]
12	46,XX, t (9;22) (q34;q11), add (13) (p11), add (20) (p13) [23]
13	46,XY, t (9;22) (q34;q11) t (16;20) (q23;q12) [3]
14	46,XX, dup (14) (q22;q32), t (9;22) (q34;q11) [5]
15	46,XX, t (4;11) (q13;p12), t (9;22) (q34;q11) [11]
16	46,XX, inv (12), t (9;22) (q34;11) [100]
17	47,XY, del (13) (q21), t (9;10;22) (q34;p14;q11) + mar 1 [3]
18	46,XY, t (1;3;9;22) (p35;p22;q34;q11) [20]
19	46,XY, t (2;9;22) (q37;q34;q11) [100]
20	46,XY, t (6;9;22) (q22; q34;q11) [3]
21	46,XY, t (3; 9; 22) (q27; q34; q11), der (21) t (21;?) p (12;?) [15]
22	47,XY, der (22), t (9;22) (q34;q11) [100]
23	45-46,XY, t (9;22) (q34;q11), der (12), t(12;14), (q10;q10), add (13), (p11.2), -14, -mar
24	46,XY, t (3; 13) (p25; q14), t(9; 22) (q34; q11) [28]/52, idem, +6,+7,+8,+19,+21, +der(22), t(9;22) (q34;q11)
25	46,XY, del (2) (p22), der (9), t(9;22) (q34;q11), der (22), t(9;22) (q34;q11), +mar 1, +mar 2 [20]
26	46,XY, t (9;22) (q34;q11), der (9), der (22q) [7]/47,XY, idem, der (22) [11]
27	45,XY, -17, t (9;22) (q34;q11), add(19) (q13.4), -mar [19]/45,XY, -17, t (9;22) (q34;q11), add(19) (q13.4) [11]